FI890245A - Förfarande för framställning av terapeutiskt användbara 1,4-disubstituerade piperidinylderivat - Google Patents
Förfarande för framställning av terapeutiskt användbara 1,4-disubstituerade piperidinylderivat Download PDFInfo
- Publication number
- FI890245A FI890245A FI890245A FI890245A FI890245A FI 890245 A FI890245 A FI 890245A FI 890245 A FI890245 A FI 890245A FI 890245 A FI890245 A FI 890245A FI 890245 A FI890245 A FI 890245A
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- therapeutically useful
- new therapeutically
- piperidinyl derivatives
- disubstituted piperidinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14664788A | 1988-01-21 | 1988-01-21 | |
US14664788 | 1988-01-21 | ||
US27990088 | 1988-12-07 | ||
US07/279,900 US5064838A (en) | 1988-01-21 | 1988-12-07 | 1,4-disubstituted-piperidinyl compounds as pain relievers |
Publications (4)
Publication Number | Publication Date |
---|---|
FI890245A0 FI890245A0 (sv) | 1989-01-17 |
FI890245A true FI890245A (sv) | 1989-07-22 |
FI90534B FI90534B (sv) | 1993-11-15 |
FI90534C FI90534C (sv) | 1994-02-25 |
Family
ID=48782796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI890245A FI90534C (sv) | 1988-01-21 | 1989-01-17 | Förfarande för framställning av terapeutiskt användbara 1,4-disubstituerade piperidinylderivat |
Country Status (18)
Country | Link |
---|---|
US (1) | US5064838A (sv) |
EP (1) | EP0325268B1 (sv) |
JP (1) | JP2967990B2 (sv) |
KR (1) | KR0131377B1 (sv) |
CN (1) | CN1035823A (sv) |
AR (2) | AR247385A1 (sv) |
AT (1) | ATE90077T1 (sv) |
AU (1) | AU615713B2 (sv) |
CA (1) | CA1330087C (sv) |
DE (1) | DE68906801T2 (sv) |
DK (1) | DK26389A (sv) |
ES (1) | ES2058346T3 (sv) |
FI (1) | FI90534C (sv) |
HU (2) | HU205073B (sv) |
NO (1) | NO174505B (sv) |
NZ (1) | NZ227643A (sv) |
PH (1) | PH27115A (sv) |
PT (1) | PT89497B (sv) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR910006138B1 (ko) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
NZ236501A (en) * | 1989-12-21 | 1992-12-23 | Merrell Dow Pharma | Piperidine derivatives and antithrombotic compositions |
US5292752A (en) * | 1989-12-21 | 1994-03-08 | Merrell Dow Pharmaceuticals Inc. | Antithrombotic compounds |
AU652759B2 (en) * | 1990-06-01 | 1994-09-08 | Aventisub Ii Inc. | (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)- 4-piperidinemethanol |
WO1991018603A1 (en) * | 1990-06-07 | 1991-12-12 | Merrell Dow Pharmaceuticals Inc. | 1-pyperidinyl alkanoylarylsulfonamide derivatives |
FR2672286B1 (fr) * | 1991-01-31 | 1994-11-18 | Synthelabo | Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique. |
WO1992020661A1 (en) * | 1991-05-22 | 1992-11-26 | Merck & Co., Inc. | N, n-diacylpiperazines |
FR2678269B1 (fr) * | 1991-06-27 | 1995-01-13 | Synthelabo | Derives de 1-(4-chlorophenyl)-2-[4-(2-phenylethyl)piperidin-1-yl]ethanol, leur application et leur preparation en therapeutique. |
US5637699A (en) * | 1992-06-29 | 1997-06-10 | Merck & Co., Inc. | Process for preparing morpholine tachykinin receptor antagonists |
US6048859A (en) | 1992-06-29 | 2000-04-11 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
US5719147A (en) * | 1992-06-29 | 1998-02-17 | Merck & Co., Inc. | Morpholine and thiomorpholine tachykinin receptor antagonists |
US5387595A (en) * | 1992-08-26 | 1995-02-07 | Merck & Co., Inc. | Alicyclic compounds as tachykinin receptor antagonists |
FR2696741B1 (fr) * | 1992-10-12 | 1994-11-25 | Synthelabo | Dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl]piperidin-1-yl] éthanol, leur préparation et leur application en thérapeutique. |
US5344830A (en) * | 1992-12-10 | 1994-09-06 | Merck & Co., Inc. | N,N-diacylpiperazine tachykinin antagonists |
US5348955A (en) * | 1993-06-22 | 1994-09-20 | Merck & Co., Inc. | N,N-diacylpiperazines |
US5610165A (en) * | 1994-02-17 | 1997-03-11 | Merck & Co., Inc. | N-acylpiperidine tachykinin antagonists |
TW385308B (en) * | 1994-03-04 | 2000-03-21 | Merck & Co Inc | Prodrugs of morpholine tachykinin receptor antagonists |
EP0796619A1 (en) * | 1996-03-21 | 1997-09-24 | Merrell Pharmaceuticals Inc. | Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders |
US6028083A (en) * | 1997-07-25 | 2000-02-22 | Hoechst Marion Roussel, Inc. | Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol |
KR100795326B1 (ko) | 1997-10-31 | 2008-01-21 | 아스비오파마 가부시키가이샤 | 아릴피페리디노프로판올 및 아릴피페라지노프로판올유도체의 제조에 유용한 화합물의 제조방법 |
US6713627B2 (en) * | 1998-03-13 | 2004-03-30 | Aventis Pharmaceuticals Inc. | Processes for the preparation of (R)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
US20050261341A1 (en) * | 1998-03-13 | 2005-11-24 | Aventis Pharmaceuticals Inc. | Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
US6277864B1 (en) | 1998-08-28 | 2001-08-21 | Aventis Pharmaceuticals Inc. | Use of R- +)-α-(2,3-dimethoxyphenyl-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol for the treatment of sleep disorders |
US6939879B2 (en) * | 1998-08-28 | 2005-09-06 | Aventis Pharmaceuticals Inc. | Use of R (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol for the treatment of substance induced insomnia |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3576810A (en) * | 1968-06-20 | 1971-04-27 | Robins Co Inc A H | 1-substituted-3-(-4)-aroylpiperidines |
GB1402889A (en) * | 1973-02-03 | 1975-08-13 | Ciba Geigy Ag | Piperidine derivatives |
FR2581993B1 (fr) * | 1985-05-14 | 1988-03-18 | Synthelabo | Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique |
KR910006138B1 (ko) * | 1986-09-30 | 1991-08-16 | 에자이 가부시끼가이샤 | 환상아민 유도체 |
-
1988
- 1988-12-07 US US07/279,900 patent/US5064838A/en not_active Expired - Fee Related
-
1989
- 1989-01-16 CA CA000588352A patent/CA1330087C/en not_active Expired - Fee Related
- 1989-01-17 FI FI890245A patent/FI90534C/sv not_active IP Right Cessation
- 1989-01-17 NZ NZ227643A patent/NZ227643A/xx unknown
- 1989-01-18 HU HU90238A patent/HU205073B/hu not_active IP Right Cessation
- 1989-01-18 HU HU89189A patent/HU202494B/hu not_active IP Right Cessation
- 1989-01-19 AR AR89313027A patent/AR247385A1/es active
- 1989-01-20 JP JP1013022A patent/JP2967990B2/ja not_active Expired - Fee Related
- 1989-01-20 PH PH38074A patent/PH27115A/en unknown
- 1989-01-20 NO NO890269A patent/NO174505B/no unknown
- 1989-01-20 PT PT89497A patent/PT89497B/pt not_active IP Right Cessation
- 1989-01-20 ES ES89100955T patent/ES2058346T3/es not_active Expired - Lifetime
- 1989-01-20 DE DE8989100955T patent/DE68906801T2/de not_active Expired - Fee Related
- 1989-01-20 DK DK026389A patent/DK26389A/da not_active Application Discontinuation
- 1989-01-20 AU AU28687/89A patent/AU615713B2/en not_active Ceased
- 1989-01-20 KR KR1019890000597A patent/KR0131377B1/ko not_active IP Right Cessation
- 1989-01-20 EP EP89100955A patent/EP0325268B1/en not_active Expired - Lifetime
- 1989-01-20 AT AT89100955T patent/ATE90077T1/de not_active IP Right Cessation
- 1989-01-21 CN CN89100339A patent/CN1035823A/zh active Pending
- 1989-05-09 AR AR89313868A patent/AR244666A1/es active
Also Published As
Publication number | Publication date |
---|---|
NO890269D0 (no) | 1989-01-20 |
ATE90077T1 (de) | 1993-06-15 |
DK26389D0 (da) | 1989-01-20 |
HUT52050A (en) | 1990-06-28 |
KR0131377B1 (ko) | 1998-04-17 |
PT89497A (pt) | 1989-10-04 |
AU615713B2 (en) | 1991-10-10 |
HU202494B (en) | 1991-03-28 |
FI90534B (sv) | 1993-11-15 |
DE68906801D1 (de) | 1993-07-08 |
DK26389A (da) | 1989-07-22 |
DE68906801T2 (de) | 1993-09-23 |
PH27115A (en) | 1993-03-16 |
JP2967990B2 (ja) | 1999-10-25 |
EP0325268B1 (en) | 1993-06-02 |
CA1330087C (en) | 1994-06-07 |
AU2868789A (en) | 1989-07-27 |
ES2058346T3 (es) | 1994-11-01 |
NZ227643A (en) | 1991-01-29 |
NO174505C (sv) | 1994-05-18 |
HU205073B (en) | 1992-03-30 |
EP0325268A1 (en) | 1989-07-26 |
NO174505B (no) | 1994-02-07 |
HU900238D0 (en) | 1990-03-28 |
KR890011840A (ko) | 1989-08-22 |
FI890245A0 (sv) | 1989-01-17 |
US5064838A (en) | 1991-11-12 |
NO890269L (no) | 1989-07-24 |
CN1035823A (zh) | 1989-09-27 |
HUT53871A (en) | 1990-12-28 |
PT89497B (pt) | 1994-03-31 |
AR244666A1 (es) | 1993-11-30 |
AR247385A1 (es) | 1994-12-29 |
FI90534C (sv) | 1994-02-25 |
JPH01224360A (ja) | 1989-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI890245A0 (sv) | Förfarande för framställning av terapeutiskt användbara 1,4-disubstituerade piperidinylderivat | |
FI890282A0 (sv) | Förfarande för framställning av terapeutiskt användbara 23,24-didehydro-25-hydroxikalciferolderivat | |
NO179639C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte piperidinforbindelser | |
FI871041A (sv) | Förfarande för framställning av terapeutiskt användbara 3,5-disubstituerade pyrokatekolderivat | |
FI905941A0 (sv) | Förfarande för framställning av terapeutiskt användbara heterocykliska 2-acylaminotiazolderivat | |
FI874459A (sv) | Förfarande för framställning av terapeutiskt användbara piperidinderivat | |
FI891338A0 (sv) | Förbättring i förfarandet för framställning av en 2',3'-dideoxi-2',3'-didehydronukleosid | |
PT87717A (pt) | Process for preparing 2,4-thiazolidinedione derivatives | |
FI873350A0 (sv) | Förfarande för framställning av terapeutiskt användbara 1,4-dihydropyridinderivat | |
FI880467A0 (sv) | Förfarande för framställning av terapeutiskt användbara substituerade 3,4-dihydro-2H-benzopyraner | |
NO175976C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater | |
HU9200771D0 (en) | Process for the production of aryl-1,2,4-triazolyn-5-on derivatives | |
FI893003A (sv) | Förfarande för framställning av terapeutiskt användbara neplanocinderivat | |
FI895662A0 (sv) | Förfarande för framställning av en 3,4-difluorsubstituerad bensen | |
FI891111A (sv) | Förfarande för framställning av 1,4-dihydropyridinderivat | |
EP0371492A3 (en) | Process for the preparation of 1,4-dihydropyridine derivatives | |
FI93216C (sv) | Analogiförfarande för framställning av terapeutiskt användbara 1,3-dioxanalkensyraderivat | |
PT86623A (pt) | Process for the preparation of derivatives of 3-aryl-5-alkylthio-4h-1,2,4-triazoles | |
FI943833A0 (sv) | Förfarande för framställning av 2,3,5,6-tetraklorpyridin | |
FI893434A (sv) | Förfarande för framställning av nya terapeutiskt användbara cykloalkyltiazolderivat | |
FI93118B (sv) | Förfarande för framställning av nya terapeutiskt användbara 1,4-diazepinderivat | |
FI93010B (sv) | Förfarande för framställning av 1,5-bensotiazepinderivat | |
FI931893A0 (sv) | Förfarande för framställning av nya terapeutiskt användbara 7,8-dihydroxi-1,2,5-oxa-, tia- och selendiazolo/3,4-f/kinoxalinderivat | |
FI92393B (sv) | Förfarande för framställning av 1,5-bensotiazepinderivat | |
FI963354A0 (sv) | Förfarande för framställning av piperidinderivat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
BB | Publication of examined application | ||
MM | Patent lapsed |
Owner name: MERRELL DOW PHARMACEUTICALS INC. |